Linmarie Sikich

Medical Associate Professor in the Department of Psychiatry and Behavioral Sciences

Psychiatry, Child & Family Mental Health & Community Psychiatry

linmarie.sikich@duke.edu

2608 Erwin Rd, Suite 300, Durham, NC 27705

2608 Erwin Rd, Suite 300, Durham, NC 27705

More About This Person

At a Glance

Credentials
1. Education

Academic Experience

Expertise

Research
1. Selected Grants

Publications

Artistic Works / Events

Teaching

Advising & Mentoring

Recognition
1. In the News

Professional Activities
1. Outreach & Engaged Scholarship

Embed Profile Data

Embed Profile Data

Selected Grants

Characterizing the (epi)genetics of oxytocin response in clinical and animal models

ResearchInvestigator · Awarded by National Institutes of Health · 2017 - 2024

Anti-psychotic Treatment

ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2016 - 2021

North Carolina Pediatric Access Line for Youth with Intellectual and Developmental Disabilities Family Partner Outreach Project (NC-PAL IDD Family Partner Outreach)

Public ServicePhysician · Awarded by The Arc of North Carolina · 2019 - 2021

A Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study to investigate the efficacy and safety of RO5285119 in children and adolescents age 5-17 with Autism Spectrum Disorder (ASD)

ResearchPrincipal Investigator · Awarded by Roche Biomedical Laboratories · 2016 - 2020

1/5-The Autism Biomarkers Consortium for Clinical Trials

ResearchCo Investigator · Awarded by Yale University · 2015 - 2020

Auditory Perception and Emotion Recognition in Young People at Risk for Psychosis

ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2019

An Open-Label Extension Study of CM-AT for the Treatment of Children with Autism

Clinical TrialPrincipal Investigator · Awarded by Curemark, LLC · 2016 - 2019

Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2018

A Multi-Center, Randomized, Double-Blind, 12 Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RO5285119 in Individuals with Autism Spectrum Disorders (ASD)

Clinical TrialPrincipal Investigator · Awarded by Roche Biomedical Laboratories · 2016 - 2018

A Double-Blind Placebo Controlled Study of CM-AT for the Treatment of Autism in Children with All Levels of Fecal Chymotrypsin

Clinical TrialPrincipal Investigator · Awarded by Curemark, LLC · 2015 - 2018

Neural circuits that regulate social motivation

ResearchInvestigator · Awarded by University of North Carolina - Chapel Hill · 2013 - 2017